Literature DB >> 9891727

Equine sarcoids.

L Goodrich1, H Gerber, E Marti, D F Antczak.   

Abstract

Sarcoids, the most common tumor of the horse, are fibroblastic, wart-like skin lesions that show variable manifestations. They are often invasive and recurrent, although they do not fulfill all criteria of malignancy. Due to their anatomic location, these tumors can sometimes cause loss of use of the horse. There is very strong evidence that sarcoids are caused by viruses closely related or identical to bovine papilloma viruses, and genetic studies have shown associations between genes in or near the equine major histocompatibility complex (MHC) and susceptibility to sarcoid. Several types of treatments have been successful in treating sarcoids, although the response to therapy is not consistent. Current treatment of sarcoids primarily involves antitumor therapy, but the development of preventative measures in the future may be directed against the causative papilloma virus. Sarcoid continues to be an important clinical entity for the equine practitioner.

Entities:  

Mesh:

Year:  1998        PMID: 9891727     DOI: 10.1016/s0749-0739(17)30189-x

Source DB:  PubMed          Journal:  Vet Clin North Am Equine Pract        ISSN: 0749-0739            Impact factor:   1.792


  7 in total

1.  Evaluation of equine papillomas, aural plaques, and sarcoids for the presence of Equine papillomavirus DNA and Papillomavirus antigen.

Authors:  Rosemary C Postey; Greg D Appleyard; Beverly A Kidney
Journal:  Can J Vet Res       Date:  2007-01       Impact factor: 1.310

2.  Transcriptional changes induced by bovine papillomavirus type 1 in equine fibroblasts.

Authors:  Z Q Yuan; L Nicolson; B Marchetti; E A Gault; M S Campo; L Nasir
Journal:  J Virol       Date:  2008-04-23       Impact factor: 5.103

3.  Papillomaviruses: a systematic review.

Authors:  Rodrigo Pinheiro Araldi; Suely Muro Reis Assaf; Rodrigo Franco de Carvalho; Márcio Augusto Caldas Rocha de Carvalho; Jacqueline Mazzuchelli de Souza; Roberta Fiusa Magnelli; Diego Grando Módolo; Franco Peppino Roperto; Rita de Cassia Stocco; Willy Beçak
Journal:  Genet Mol Biol       Date:  2017-02-16       Impact factor: 1.771

4.  Segmental Posthetomy in a Four Stallions Case Series.

Authors:  Adriana Palozzo; Gianluca Celani; Giulia Guerri; Paola Straticò; Vincenzo Varasano; Lucio Petrizzi
Journal:  Animals (Basel)       Date:  2021-04-16       Impact factor: 2.752

5.  ALVAC-fIL2, a feline interleukin-2 immunomodulator, as a treatment for sarcoids in horses: A pilot study.

Authors:  Corey Saba; Randall Eggleston; Andrew Parks; John Peroni; Eric Sjoberg; Shelbe Rice; Jesse Tyma; Jarred Williams; Deborah Grosenbaugh; A Timothy Leard
Journal:  J Vet Intern Med       Date:  2022-04-13       Impact factor: 3.175

6.  Equine sarcoids: Bovine Papillomavirus type 1 transformed fibroblasts are sensitive to cisplatin and UVB induced apoptosis and show aberrant expression of p53.

Authors:  Margaret Finlay; Zhengqiang Yuan; Iain M Morgan; M Saveria Campo; Lubna Nasir
Journal:  Vet Res       Date:  2012-12-04       Impact factor: 3.683

7.  In vitro assessment of triterpenoids NVX-207 and betulinyl-bis-sulfamate as a topical treatment for equine skin cancer.

Authors:  Lisa Annabel Weber; Anne Funtan; Reinhard Paschke; Julien Delarocque; Jutta Kalbitz; Jessica Meißner; Karsten Feige; Manfred Kietzmann; Jessika-Maximiliane V Cavalleri
Journal:  PLoS One       Date:  2020-11-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.